Table 2 AUC (95% CI) of the 15 screened gene signatures in Time dependent ROC analyses
From: Novel immune-related genes in the tumor microenvironment with prognostic value in breast cancer
genes | AUC (95% CI) | ||
|---|---|---|---|
1-year | 3-year | 5-year | |
CD226 | 0.73 (0.6136–0.8428) | 0.62 (0.5533–0.6925) | 0.57 (0.5007–0.6405) |
KLRD1 | 0.73 (0.6079–0.8430) | 0.60 (0.5235–0.6718) | 0.54 (0.4685–0.6178) |
KLRC4-KLRK1 | 0.72 (0.6063–0.8328) | 0.60 (0.5295–0.6785) | 0.56 (0.4868–0.6346) |
IL2 | 0.60 (0.4710–0.7387) | 0.60 (0.5310–0.6695) | 0.61 (0.5418–0.6779) |
KLRK1 | 0.67 (0.5400–0.7990) | 0.59 (0.5220–0.6642) | 0.54 (0.4681–0.6149) |
ITK | 0.67 (0.5445–0.8050) | 0.62 (0.5503–0.6953) | 0.57 (0.4975–0.6413) |
SPN | 0.64 (0.5094–0.7626) | 0.62 (0.5468–0.6895) | 0.57 (0.5014–0.6478) |
SLAMF1 | 0.64 (0.5083–0.7764) | 0.61 (0.5350–0.6804) | 0.54 (0.4724–0.6145) |
CD1C | 0.63 (0.4879–0.7658) | 0.63 (0.5577–0.7070) | 0.60 (0.5286–0.6700) |
FASLG | 0.62 (0.5020–0.7360) | 0.61 (0.5363–0.6765) | 0.56 (0.4848–0.6297) |
CD40LG | 0.62 (0.4941–0.7477) | 0.62 (0.5423–0.6935) | 0.59 (0.5194–0.6602) |
TBX21 | 0.62 (0.5021–0.7298) | 0.58 (0.5084–0.6474) | 0.54 (0.4651–0.6066) |
IL7 | 0.60 (0.4624–0.7438) | 0.56 (0.4839–0.6391) | 0.52 (0.4531–0.5967) |
LAT | 0.61 (0.4995–0.7263) | 0.56 (0.4917–0.6347) | 0.53 (0.4583–0.6098) |
ITGAX | 0.59 (0.4649–0.7191) | 0.55 (0.4806–0.6274) | 0.56 (0.4878–0.6321) |